A detailed history of Schonfeld Strategic Advisors LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 507,736 shares of PCRX stock, worth $9.89 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
507,736
Holding current value
$9.89 Million
% of portfolio
0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $5.94 Million - $14.5 Million
507,736 New
507,736 $7.65 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $2.63 Million - $3.43 Million
100,053 New
100,053 $3.38 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $3.71 Million - $4.88 Million
102,823 New
102,823 $4.12 Million
Q4 2022

Feb 14, 2023

SELL
$38.19 - $57.45 $199,084 - $299,486
-5,213 Reduced 15.03%
29,472 $1.14 Million
Q3 2022

Nov 14, 2022

SELL
$51.24 - $58.89 $157,921 - $181,498
-3,082 Reduced 8.16%
34,685 $1.85 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $1.94 Million - $3.08 Million
37,767 New
37,767 $2.2 Million
Q4 2021

Feb 14, 2022

SELL
$47.97 - $62.21 $5.71 Million - $7.4 Million
-118,970 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$54.64 - $61.3 $2.81 Million - $3.15 Million
51,381 Added 76.02%
118,970 $6.66 Million
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $2.49 Million - $2.94 Million
42,026 Added 164.4%
67,589 $4.1 Million
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $1.52 Million - $2.01 Million
25,563 New
25,563 $1.79 Million
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $661,157 - $868,006
-13,100 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $680,807 - $825,300
13,100 New
13,100 $788,000
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $337,783 - $575,438
-10,967 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $311,462 - $556,026
10,967 New
10,967 $368,000
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $2.98 Million - $3.85 Million
-82,200 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $449,315 - $566,874
12,600 Added 18.1%
82,200 $3.13 Million
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $373,014 - $489,294
10,200 Added 17.17%
69,600 $3.03 Million
Q1 2019

May 15, 2019

SELL
$36.47 - $42.17 $1.44 Million - $1.67 Million
-39,611 Reduced 40.01%
59,400 $2.26 Million
Q4 2018

Feb 14, 2019

BUY
$41.31 - $52.16 $4.09 Million - $5.16 Million
99,011 New
99,011 $4.26 Million
Q2 2018

Aug 14, 2018

SELL
$27.5 - $39.8 $1.53 Million - $2.22 Million
-55,731 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$29.98 - $46.35 $1.67 Million - $2.58 Million
55,731 New
55,731 $1.74 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.